Total Payments
$2,845
2024 Payments
$464.51
Companies
29
Transactions
168
Medicare Patients
1,185
Medicare Billing
$119,032
Payment Breakdown by Category
Food & Beverage$2,839 (99.8%)
Education$6.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,839 | 167 | 99.8% |
| Education | $6.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $418.58 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $375.41 | 23 | $0 (2024) |
| PFIZER INC. | $359.50 | 21 | $0 (2024) |
| Amgen Inc. | $322.26 | 17 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $212.26 | 13 | $0 (2020) |
| GlaxoSmithKline, LLC. | $152.98 | 8 | $0 (2024) |
| Lilly USA, LLC | $126.93 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $100.86 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $79.41 | 6 | $0 (2020) |
| Merck Sharp & Dohme LLC | $66.85 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $464.51 | 24 | Bayer Healthcare Pharmaceuticals Inc. ($66.98) |
| 2023 | $274.50 | 13 | PFIZER INC. ($83.27) |
| 2020 | $213.65 | 13 | Novo Nordisk Inc ($62.60) |
| 2019 | $754.68 | 47 | Novo Nordisk Inc ($144.94) |
| 2018 | $975.63 | 60 | AstraZeneca Pharmaceuticals LP ($180.99) |
| 2017 | $162.34 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($38.55) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: VACCINE | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: LIVER DISEASE | ||||||
| 08/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Obesity | ||||||
| 07/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.84 | General |
| 07/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardio-renal | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardio-renal | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: UROLOGY | ||||||
| 05/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.71 | General |
| Category: PSYCHIATRY | ||||||
| 04/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardio-renal | ||||||
| 03/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: VACCINES | ||||||
| 03/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: VACCINE | ||||||
| 03/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: PSYCHIATRY | ||||||
| 01/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardio-renal | ||||||
| 01/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Oncology | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 328 | 566 | $88,609 | $35,076 |
| 2022 | 4 | 341 | 574 | $98,345 | $38,286 |
| 2021 | 4 | 213 | 274 | $49,121 | $21,433 |
| 2020 | 6 | 303 | 422 | $66,897 | $24,237 |
Total Patients
1,185
Total Services
1,836
Medicare Billing
$119,032
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 387 | $66,102 | $24,801 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $10,105 | $5,946 | 58.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 99 | $11,940 | $4,170 | 34.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 32 | 33 | $462.00 | $159.50 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 397 | $70,498 | $25,127 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 48 | 48 | $9,267 | $6,214 | 67.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 110 | $13,853 | $5,029 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 19 | $4,727 | $1,916 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 150 | $26,514 | $9,997 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 52 | 52 | $10,414 | $6,793 | 65.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 55 | $8,334 | $2,668 | 32.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 17 | $3,859 | $1,975 | 51.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 104 | 178 | $32,040 | $9,826 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 78 | 78 | $15,600 | $8,953 | 57.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 54 | $8,640 | $1,785 | 20.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 34 | 45 | $3,978 | $1,469 | 36.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 16 | $3,525 | $1,248 | 35.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 40 | 51 | $3,114 | $955.99 | 30.7% |
About Dr. Michael Parslow, DO
Dr. Michael Parslow, DO is a Family Medicine healthcare provider based in Rome, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1437569746.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Parslow, DO has received a total of $2,845 in payments from pharmaceutical and medical device companies, with $464.51 received in 2024. These payments were reported across 168 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,839).
As a Medicare-enrolled provider, Parslow has provided services to 1,185 Medicare beneficiaries, totaling 1,836 services with total Medicare billing of $119,032. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Rome, NY
- Active Since 05/08/2014
- Last Updated 08/19/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437569746
Products in Payments
- FARXIGA (Drug) $307.33
- CHANTIX (Drug) $244.85
- Ozempic (Drug) $186.34
- Aimovig (Biological) $168.36
- TRELEGY ELLIPTA (Drug) $123.54
- Tresiba (Drug) $112.97
- Kerendia (Drug) $100.86
- SPIRIVA RESPIMAT (Drug) $85.08
- REXULTI (Drug) $83.29
- Prolia (Biological) $69.39
- PAXLOVID (Drug) $66.85
- TRULICITY (Drug) $60.74
- XIFAXAN (Drug) $57.68
- AJOVY (Drug) $53.84
- Repatha (Biological) $52.52
- Saxenda (Drug) $51.35
- Motegrity (Drug) $49.43
- STIOLTO RESPIMAT (Drug) $49.37
- Victoza (Drug) $48.40
- Cologuard Collection Kit (Device) $48.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rome
Anthony Cotronea, Md, MD
Family Medicine — Payments: $17,568
Family Medicine $17,568
Randolph Sumner, Md, MD
Family Medicine — Payments: $16,942
Family Medicine $16,942
Nicoletta Tallandini Cotronea, M.d, M.D
Family Medicine — Payments: $15,069
Family Medicine $15,069
Shalini Reddy, Md, MD
Family Medicine — Payments: $13,639
Family Medicine $13,639
Brian Mcniece, Md, MD
Family Medicine — Payments: $12,565
Family Medicine $12,565
John-Scott Carroll, Md, MD
Family Medicine — Payments: $11,796
Family Medicine $11,796